Yonghong Sun

1.7k total citations
47 papers, 1.3k citations indexed

About

Yonghong Sun is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yonghong Sun has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Yonghong Sun's work include Cancer Mechanisms and Therapy (7 papers), Peptidase Inhibition and Analysis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Yonghong Sun is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Peptidase Inhibition and Analysis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Yonghong Sun collaborates with scholars based in China and United States. Yonghong Sun's co-authors include Chune Ren, Zhenhai Yu, Pengyun Qiao, Xue Han, Tingting Yang, Chao Lü, Shijun Lv, Xiaoxiang Zheng, Li Wang and Mingen Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Yonghong Sun

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghong Sun China 22 726 363 236 154 136 47 1.3k
Jing Ni China 19 654 0.9× 422 1.2× 165 0.7× 134 0.9× 129 0.9× 66 1.2k
Fiona Furlong Ireland 18 887 1.2× 369 1.0× 326 1.4× 170 1.1× 77 0.6× 34 1.3k
Chao Xiao China 19 513 0.7× 250 0.7× 196 0.8× 145 0.9× 90 0.7× 37 1.1k
Anica Dricu Romania 26 811 1.1× 423 1.2× 374 1.6× 169 1.1× 67 0.5× 78 1.6k
Wenting Xu China 18 872 1.2× 412 1.1× 424 1.8× 168 1.1× 104 0.8× 46 1.6k
Man Wu China 20 571 0.8× 146 0.4× 163 0.7× 152 1.0× 106 0.8× 60 1.1k
Wei Fu China 18 799 1.1× 215 0.6× 212 0.9× 125 0.8× 216 1.6× 38 1.5k
Yang‐Sook Chun South Korea 24 1.1k 1.6× 704 1.9× 204 0.9× 150 1.0× 103 0.8× 41 1.9k

Countries citing papers authored by Yonghong Sun

Since Specialization
Citations

This map shows the geographic impact of Yonghong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghong Sun more than expected).

Fields of papers citing papers by Yonghong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghong Sun. The network helps show where Yonghong Sun may publish in the future.

Co-authorship network of co-authors of Yonghong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghong Sun. A scholar is included among the top collaborators of Yonghong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghong Sun. Yonghong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiang, et al.. (2025). Immunogenicity and safety of varicella vaccine co-administered with seasonal influenza vaccine in healthy children aged 7-12 years in China. International Journal of Infectious Diseases. 162. 108212–108212.
2.
Han, Xue, et al.. (2024). Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis. Frontiers of Medicine. 18(2). 344–356. 9 indexed citations
3.
Xu, Yurui, et al.. (2023). Effect of different chemotherapy schemes on early-stage breast cancer patients with Low HER-2 expression. Pakistan Journal of Medical Sciences. 39(5). 1355–1360. 3 indexed citations
4.
Sun, Yonghong, et al.. (2023). MFAP2 promotes HSCs activation through FBN1/TGF‐β/Smad3 pathway. Journal of Cellular and Molecular Medicine. 27(21). 3235–3246. 7 indexed citations
5.
6.
Zhang, Yun, et al.. (2022). Tricalcium phosphate particles promote pyroptotic death of calvaria osteocytes through the ROS/NLRP3/Caspase-1 signaling axis in amouse osteolysis model. International Immunopharmacology. 107. 108699–108699. 28 indexed citations
7.
Ren, Chune, Xue Han, Chao Lü, et al.. (2021). Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Cell Death and Differentiation. 29(2). 381–392. 78 indexed citations
8.
Lü, Chao, Chune Ren, Tingting Yang, et al.. (2020). A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer. Molecular Cancer Research. 18(5). 787–796. 24 indexed citations
9.
Lü, Chao, Chune Ren, Tingting Yang, et al.. (2020). Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation. Theranostics. 10(19). 8606–8618. 19 indexed citations
10.
Yang, Tingting, Chune Ren, Chao Lü, et al.. (2019). Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer. Cancer Research. 79(20). 5233–5244. 72 indexed citations
11.
Yang, Tingting, Chune Ren, Pengyun Qiao, et al.. (2019). Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene. 39(3). 720–721. 85 indexed citations
12.
Yang, Tingting, Chune Ren, Pengyun Qiao, et al.. (2018). PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene. 37(45). 5997–6009. 101 indexed citations
13.
14.
15.
Sun, Yonghong, et al.. (2015). ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate. Tumor Biology. 36(10). 7599–7606. 16 indexed citations
16.
Sun, Yonghong, et al.. (2014). [The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].. PubMed. 28(2). 129–32. 1 indexed citations
17.
Xu, Mingen, et al.. (2006). Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro1. Acta Pharmacologica Sinica. 27(2). 229–236. 25 indexed citations
18.
Wang, Bolin, et al.. (2004). Oral Presentations 3. British Journal of Cancer. 91(S1). S12–S13. 1 indexed citations
19.
Wang, Dong‐An, Linxian Feng, Jian Ji, et al.. (2003). Novel human endothelial cell‐engineered polyurethane biomaterials for cardiovascular biomedical applications. Journal of Biomedical Materials Research Part A. 65A(4). 498–510. 26 indexed citations
20.
Wang, Dong‐An, et al.. (2001). Blends of stearyl poly(ethylene oxide) coupling‐polymer in chitosan as coating materials for polyurethane intravascular catheters. Journal of Biomedical Materials Research. 58(4). 372–383. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Ni Breakdown of academic impact, for papers by Fiona Furlong Breakdown of academic impact, for papers by Chao Xiao Breakdown of academic impact, for papers by Anica Dricu Breakdown of academic impact, for papers by Wenting Xu Breakdown of academic impact, for papers by Man Wu Breakdown of academic impact, for papers by Wei Fu Breakdown of academic impact, for papers by Yang‐Sook Chun
Rankless by CCL
2026